News
-
-
-
-
COMMUNIQUÉ DE PRESSE
ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease
ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease. Phase Ib/II study evaluates Actileucel for GvHD prevention -
COMMUNIQUÉ DE PRESSE
tick Trading Software AG: sino customers successfully trade cryptocurrencies via the TBMX platform
tick Trading Software AG's TBMX platform enables successful crypto trading for sino customers with stability, speed, and security. More than 30 cryptocurrencies can now be traded with limit orders -
-
COMMUNIQUÉ DE PRESSE
Live from ESMO | Hengrui Debuts Exhibition Booth with Landmark Data Showcasing Pharma's Emerging Innovation Power
Hengrui Pharma debuts exhibition booth at ESMO Congress, showcasing 46 studies and fostering global academic exchange. President Jo Feng highlights company's commitment to innovation and patient-centric approach -
COMMUNIQUÉ DE PRESSE
Newmark Expands Advisory Capabilities in the Middle East with Key Hires
Newmark Group, Inc. expands its Advisory capabilities in the Middle East by hiring new senior executives for its Middle East Advisory practice in Dubai, showcasing commitment to regional growth and client solutions -
-
COMMUNIQUÉ DE PRESSE
Original-Research: Scandinavian Astor Group AB (von NuWays AG): BUY
Scandinavian Astor Group AB's Q3 results show strong sales growth of 79% yoy, reaching SEK 79m, and a significant EBITDA margin increase to 19% in a 'weak' quarter. Analyst maintains BUY rating with SEK 56.00 target price
